Inhibikase Therapeutics (IKT) Price to Sales (2020 - 2024)
Inhibikase Therapeutics' Price to Sales came in at 9703290.64 for Q3 2024, compared with 22.99 a year earlier.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Price to Sales (2020 - 2024) Analysis & Trends
For FY2023, Inhibikase Therapeutics' Price to Sales was 30.16, down 70.5% from FY2022.
- Going back by year, Price to Sales was 102.19 in FY2022, 8.63 in FY2021 (-89.4%) and 81.13 in FY2020.
- The Q3 2024 figure represents the highest quarterly Price to Sales in data going back to Q4 2020.
- Year-over-year, Price to Sales increased in three of the last six quarters, with growth averaging 76.0%.
- The fastest year-over-year change in Price to Sales over five years came in Q1 2023 (growth of 571.1%), and the weakest in Q3 2023 (a decline of 93.8%).
- Business Quant data shows IKT's Price to Sales at 109.73 (Q2 2024), 71.38 (Q1 2024) and 30.16 (Q4 2023) in the three quarters before Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Inhibikase Therapeutics | 349.14 Mn | -236.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 9.70 Mn |
| Jun 30, 2024 | 109.73 |
| Mar 31, 2024 | 71.38 |
| Dec 31, 2023 | 30.16 |
| Sep 30, 2023 | 22.99 |
| Jun 30, 2023 | 75.86 |
| Mar 31, 2023 | 144.06 |
| Dec 31, 2022 | 102.19 |
| Sep 30, 2022 | 371.37 |
| Jun 30, 2022 | 48.96 |
| Mar 31, 2022 | 21.46 |
| Dec 31, 2021 | 8.63 |
| Sep 30, 2021 | 14.62 |
| Jun 30, 2021 | 11.51 |
| Mar 31, 2021 | 32.95 |
| Dec 31, 2020 | 81.13 |
API Access
Inhibikase Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();